Latest News
Aqemia and Sanofi expand drug discovery collaboration with new research target
17 July 2026 - Generative AI drug development company Aqemia announced on Friday an expansion of its multi-year drug discovery collaboration with French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) with the nomination of a new the...
Camurus' FDA accepts CAM2029 NDA resubmission for acromegaly, sets December decision date
17 July 2026 - Swedish biopharmaceutical company Camurus AB (STO:CAMX) said on Friday that the US Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application for CAM2029, an extended-release octreotide injection fo...
Vanda Pharmaceuticals reports positive EMA opinion on orphan drug designation for imsidolimab in generalised pustular psoriasis
17 July 2026 - US pharmaceutical company Vanda Pharmaceuticals Inc (Nasdaq:VNDA) announced on Thursday that the Committee for Orphan Medicinal Products at the European Medicines Agency (EMA) has adopted a positive opinion recommending orphan drug des...
Raidium introduces AI-powered oncology imaging workflow for US cancer centres
17 July 2026 - AI-native radiology company Raidium announced on Thursday the US launch of Raidium Read (R.Read), applying its AI-native imaging solution initially to oncology research centres.Raidium has already been deployed at Moffitt Cancer Center...
World Health Organization approves 'codabakalner' as International Nonproprietary Name for Spinogenix's SPG601
17 July 2026 - Clinical-stage biopharmaceutical company Spinogenix Inc announced on Thursday that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization has approved 'codabakalner' as the non-propriet...